Remedium Pdrn 2.2ml×3 Wrinkle Reducing Hyaluronic Injection

Name: Remedium Pdrn 2.2ml×3 Wrinkle Reducing Hyaluronic Injection
Brand: OPALIS Biomedical Limited
SKU: 2176753972

Shandong, ChinaOPALIS Biomedical Limited

US$45.00

5-49 Pieces

US$40.00

50-99 Pieces

US$35.00

100-499 Pieces

US$30.00

500+ Pieces

Product profile

Customization

Available

Disinfection

Color

Transparent

Model NO.

2.2ml*3

Application

Face

Material

Hyaluronic Acid

Disinfection Required

Disinfection

Form

Gel

Ingredient

Hyaluronic Acid

Packing

Box

Model Number

3*2.2ml

Duration

6-8months

Package

3*2.2ml

OEM/Private

Support

Concentration

7.5mg/Ml

Storage

2-25℃

Supply Type

Obm(Original Brand Manufacturing)

MOQ

Transport Package

Box

Specification

3*2.2ml

Trademark

pdrn

Origin

Korea

Key features

PDRN and Hyaluronic Acid Formula: Promotes cellular regeneration, hydration, and collagen production for skin repair.

Long-Lasting Results: Results typically last between 6 to 12 months depending on individual factors.

Visible Results in Weeks: Improvements in skin texture and elasticity can be seen within 2 to 4 weeks.

OEM Support Available: Original Brand Manufacturing (OBM) and private label options are supported.

Transparent Gel Form: Hyaluronic acid based gel with 7.5mg/Ml concentration for precise injection.

Professional Consultation Required: Treatment requires assessment by a qualified professional for safety and efficacy.

Standard Packaging: Comes in a box containing 3 units of 2.2ml each.

Company profile

OPALIS Biomedical LimitedShandong, China

Business Type: Manufacturer/Factory, Trading Company, Group CorporationExport Year: 2021-08-02Nearest Port: HongKong, QingDaoAverage Response Time: ≤1.09hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, DDP, EXW, CIF

AI-Powered supplier vetting

SummaryOPALIS Biomedical Limited is a China-based limited company in Qingdao, Shandong, described as a trading company, manufacturer/factory, and group corporation. It specializes in medical aesthetic products, including dermal fillers, hyaluronic acid gels, injections, collagen products, mesotherapy products, PLLA, skin boosters, and related items. The supplier reports ISO 9001 certification, 6–10 years of total R&D engineer experience, and two production lines. It also states that it provides OEM/ODM and customized products, supported by packaging design, consumables selection, custom formulations, and finished-product delivery. A 24-hour sales and after-sales service team is reported. The supplier claims that its products are popular in many countries, but no specific customer names, markets, order references, or case details are provided. Quality-control staffing is listed as n/a, so quality-control capacity cannot be assessed. Financial credibility cannot be assessed from the available non-financial evidence.

Supplier typeOPALIS Biomedical Limited is identified as a trading company, manufacturer/factory, and group corporation, with a limited-company ownership structure and operations in Qingdao, Shandong, China. This indicates a multi-role supplier profile, although the slices do not clarify the relative scale of its trading, manufacturing, or group activities.

CertificationsThe supplier explicitly reports certification under ISO 9001. This provides direct evidence of a certified quality-management system, although no certification scope, issuing body, or validity period is supplied.

After-Sales capabilityThe supplier states that it has a sales and after-sales team offering 24-hour service and welcomes customers to visit its factory. This is explicit evidence of stated continuous service availability, though staffing size and service-performance records are not provided.

R&D capabilityThe supplier reports 6–10 years of total R&D engineer experience and lists a broad range of medical aesthetic products, including dermal fillers, hyaluronic acid gels, collagen injections, mesotherapy, PLLA, skin boosters, and other products. This supports relevant product-development experience, but there is no direct evidence of patents, proprietary technologies, new-product launches, or dedicated R&D resources.

Customization capabilityThe supplier explicitly offers customized products and OEM/ODM processing, covering packaging design, consumables selection, custom formulations, and finished-product delivery. This indicates an end-to-end customization offering, although minimum order quantities, development timelines, and technical limitations are not stated.

Product Q&A

Q:How soon will I see results?

Results from Remedium PDRN treatments can typically be seen within 2 to 4 weeks. This innovative skin rejuvenation therapy promotes cellular regeneration and improves skin texture, hydration, and elasticity. Individual results may vary based on skin type and condition. For optimal outcomes, a series of treatments may be recommended. Always consult with a qualified practitioner for personalised advice tailored to your aesthetic goals.

Q:How long do the results last?

The results of Remedium PDRN treatments typically last between 6 to 12 months, depending on individual factors such as skin type and age. This innovative therapy enhances skin hydration, elasticity, and overall appearance by promoting cellular regeneration. To maintain optimal results, a personalised treatment plan is recommended and can be discussed during your consultation at our aesthetic clinic.

Q:Is Remedium PDRN suitable for everyone?

Remedium PDRN is generally suitable for a wide range of individuals seeking skin rejuvenation and repair. However, it may not be recommended for those with specific allergies, active infections, or certain medical conditions. A thorough consultation with a qualified professional is essential to determine if Remedium PDRN is appropriate for your unique needs and skin type. Always prioritise safety by discussing any concerns during your aesthetic treatment consultation.